Prev：pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer(A21020-2.65)
Next：Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors(A21020-2.53)
